A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience - Study Protocol

Amir Anoshiravani, Homayoon Vahedi, Siavosh Nasseri-Moghaddam, Hafez Fakheri, Fariborz Mansour-Ghanaei, Iradj Maleki, Hasan Vosoghinia, Mohammad Reza Ghadir, Ahmad Hormati, Nayyereh Aminisani, Amir Reza Radmard, Bardia Khosravi, Bahar Saberzadeh-Ardestani, Masoud Malekzadeh, Sudabeh Alatab, Anahita Sadeghi, Sarvenaz Salahi, Ali Reza Sima, Reza Malekzadeh



The COVID-19 pandemic has affected the health care infrastructure dramatically, with abundant resources necessarily being redirected to COVID-19 patients and their care. Also, patients with chronic diseases like inflammatory bowel disease (IBD) may be affected in several ways during this pandemic.


 We used the Iranian registry of Crohn’s and colitis (IRCC) infrastructure. We called and sent messages to follow-up and support the care of all registered patients. Besides, we prepared and distributed educational materials for these patients and physicians to reduce the risk of COVID-19 infection. We risk-stratified them and prepared outpatient clinics and hospitalization guidance for IBD patients.


 Of 13165 Iranian patients with IBD, 51 have been diagnosed as having COVID-19. IBD patients made 1920 hotline calls. Among the patients with suspicious presentations, 14 COVID-19 infections were diagnosed. Additionally, 1782 patients with IBD from five provinces actively phone-called among whom 28 definite cases were diagnosed.


IBD patients' follow-up could help in diagnosing the affected IBD patients with COVID-19. Additionally, the performance of protective actions and preparing the patients and physicians for decisive proceedings are the principles of protection of IBD patients.


Protocols, Care, Inflammatory bowel disease, COVID-19

Full Text:


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.